nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—forelimb zeugopod—muscle cancer	0.0878	0.225	CbGeAlD
Trandolapril—CES1—larynx—muscle cancer	0.0769	0.197	CbGeAlD
Trandolapril—ACE—hindlimb—muscle cancer	0.0397	0.102	CbGeAlD
Trandolapril—ACE—arm—muscle cancer	0.0379	0.097	CbGeAlD
Trandolapril—ACE—appendage—muscle cancer	0.0341	0.0872	CbGeAlD
Trandolapril—SLC15A1—renal system—muscle cancer	0.0119	0.0306	CbGeAlD
Trandolapril—ACE—embryo—muscle cancer	0.0113	0.0289	CbGeAlD
Trandolapril—ACE—smooth muscle tissue—muscle cancer	0.00889	0.0228	CbGeAlD
Trandolapril—SLC15A1—vagina—muscle cancer	0.00865	0.0221	CbGeAlD
Trandolapril—CES1—head—muscle cancer	0.00861	0.022	CbGeAlD
Trandolapril—ACE—renal system—muscle cancer	0.00856	0.0219	CbGeAlD
Trandolapril—CES1—testis—muscle cancer	0.00832	0.0213	CbGeAlD
Trandolapril—ACE—cardiac atrium—muscle cancer	0.00767	0.0196	CbGeAlD
Trandolapril—SLC15A2—renal system—muscle cancer	0.00746	0.0191	CbGeAlD
Trandolapril—ACE—bone marrow—muscle cancer	0.00647	0.0166	CbGeAlD
Trandolapril—ACE—head—muscle cancer	0.00573	0.0147	CbGeAlD
Trandolapril—ACE—testis—muscle cancer	0.00553	0.0142	CbGeAlD
Trandolapril—SLC15A2—vagina—muscle cancer	0.00541	0.0138	CbGeAlD
Trandolapril—SLC15A2—head—muscle cancer	0.00499	0.0128	CbGeAlD
Trandolapril—SLC15A2—testis—muscle cancer	0.00482	0.0123	CbGeAlD
Trandolapril—Breast disorder—Methotrexate—muscle cancer	0.00147	0.00242	CcSEcCtD
Trandolapril—Vertigo—Etoposide—muscle cancer	0.00147	0.00242	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00147	0.00241	CcSEcCtD
Trandolapril—Leukopenia—Etoposide—muscle cancer	0.00147	0.00241	CcSEcCtD
Trandolapril—Abdominal pain—Dactinomycin—muscle cancer	0.00146	0.0024	CcSEcCtD
Trandolapril—Body temperature increased—Dactinomycin—muscle cancer	0.00146	0.0024	CcSEcCtD
Trandolapril—Cardiac failure—Doxorubicin—muscle cancer	0.00145	0.00237	CcSEcCtD
Trandolapril—Loss of consciousness—Etoposide—muscle cancer	0.00144	0.00236	CcSEcCtD
Trandolapril—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00144	0.00236	CcSEcCtD
Trandolapril—Decreased appetite—Vincristine—muscle cancer	0.00143	0.00235	CcSEcCtD
Trandolapril—Cough—Etoposide—muscle cancer	0.00143	0.00235	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Vincristine—muscle cancer	0.00142	0.00234	CcSEcCtD
Trandolapril—Fatigue—Vincristine—muscle cancer	0.00142	0.00234	CcSEcCtD
Trandolapril—Hyponatraemia—Doxorubicin—muscle cancer	0.00142	0.00232	CcSEcCtD
Trandolapril—Constipation—Vincristine—muscle cancer	0.00141	0.00232	CcSEcCtD
Trandolapril—Pain in extremity—Doxorubicin—muscle cancer	0.00141	0.00232	CcSEcCtD
Trandolapril—Osteoarthritis—Doxorubicin—muscle cancer	0.00141	0.00232	CcSEcCtD
Trandolapril—Chest pain—Etoposide—muscle cancer	0.00139	0.00229	CcSEcCtD
Trandolapril—Eosinophilia—Methotrexate—muscle cancer	0.00139	0.00229	CcSEcCtD
Trandolapril—Migraine—Doxorubicin—muscle cancer	0.00139	0.00228	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00138	0.00227	CcSEcCtD
Trandolapril—Pancreatitis—Methotrexate—muscle cancer	0.00138	0.00227	CcSEcCtD
Trandolapril—Discomfort—Etoposide—muscle cancer	0.00138	0.00226	CcSEcCtD
Trandolapril—Hypersensitivity—Dactinomycin—muscle cancer	0.00136	0.00223	CcSEcCtD
Trandolapril—Gastrointestinal pain—Vincristine—muscle cancer	0.00135	0.00221	CcSEcCtD
Trandolapril—Cardiac arrest—Doxorubicin—muscle cancer	0.00134	0.0022	CcSEcCtD
Trandolapril—Pancytopenia—Methotrexate—muscle cancer	0.00134	0.00219	CcSEcCtD
Trandolapril—Infection—Etoposide—muscle cancer	0.00133	0.00218	CcSEcCtD
Trandolapril—Asthenia—Dactinomycin—muscle cancer	0.00133	0.00217	CcSEcCtD
Trandolapril—Blood creatinine increased—Doxorubicin—muscle cancer	0.00132	0.00217	CcSEcCtD
Trandolapril—Neutropenia—Methotrexate—muscle cancer	0.00132	0.00216	CcSEcCtD
Trandolapril—Thrombocytopenia—Etoposide—muscle cancer	0.00131	0.00215	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00131	0.00215	CcSEcCtD
Trandolapril—Tachycardia—Etoposide—muscle cancer	0.0013	0.00214	CcSEcCtD
Trandolapril—Abdominal pain—Vincristine—muscle cancer	0.0013	0.00214	CcSEcCtD
Trandolapril—Body temperature increased—Vincristine—muscle cancer	0.0013	0.00214	CcSEcCtD
Trandolapril—Liver function test abnormal—Doxorubicin—muscle cancer	0.0013	0.00214	CcSEcCtD
Trandolapril—Skin disorder—Etoposide—muscle cancer	0.0013	0.00213	CcSEcCtD
Trandolapril—Erectile dysfunction—Methotrexate—muscle cancer	0.0013	0.00213	CcSEcCtD
Trandolapril—Dry skin—Doxorubicin—muscle cancer	0.00129	0.00212	CcSEcCtD
Trandolapril—Hyperhidrosis—Etoposide—muscle cancer	0.00129	0.00212	CcSEcCtD
Trandolapril—Photosensitivity reaction—Methotrexate—muscle cancer	0.00129	0.00211	CcSEcCtD
Trandolapril—Breast disorder—Doxorubicin—muscle cancer	0.00127	0.00209	CcSEcCtD
Trandolapril—Anorexia—Etoposide—muscle cancer	0.00127	0.00209	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00127	0.00208	CcSEcCtD
Trandolapril—Diarrhoea—Dactinomycin—muscle cancer	0.00126	0.00207	CcSEcCtD
Trandolapril—Drowsiness—Methotrexate—muscle cancer	0.00126	0.00206	CcSEcCtD
Trandolapril—Infestation NOS—Methotrexate—muscle cancer	0.00126	0.00206	CcSEcCtD
Trandolapril—Infestation—Methotrexate—muscle cancer	0.00126	0.00206	CcSEcCtD
Trandolapril—Depression—Methotrexate—muscle cancer	0.00125	0.00205	CcSEcCtD
Trandolapril—Hypotension—Etoposide—muscle cancer	0.00125	0.00205	CcSEcCtD
Trandolapril—Gastritis—Doxorubicin—muscle cancer	0.00125	0.00205	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00124	0.00204	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00124	0.00204	CcSEcCtD
Trandolapril—Renal failure—Methotrexate—muscle cancer	0.00123	0.00203	CcSEcCtD
Trandolapril—Abdominal distension—Doxorubicin—muscle cancer	0.00123	0.00201	CcSEcCtD
Trandolapril—Hypersensitivity—Vincristine—muscle cancer	0.00122	0.002	CcSEcCtD
Trandolapril—Eosinophilia—Doxorubicin—muscle cancer	0.00121	0.00198	CcSEcCtD
Trandolapril—Sweating—Methotrexate—muscle cancer	0.0012	0.00198	CcSEcCtD
Trandolapril—Paraesthesia—Etoposide—muscle cancer	0.0012	0.00197	CcSEcCtD
Trandolapril—Pancreatitis—Doxorubicin—muscle cancer	0.0012	0.00196	CcSEcCtD
Trandolapril—Dyspnoea—Etoposide—muscle cancer	0.00119	0.00196	CcSEcCtD
Trandolapril—Somnolence—Etoposide—muscle cancer	0.00119	0.00195	CcSEcCtD
Trandolapril—Angina pectoris—Doxorubicin—muscle cancer	0.00119	0.00195	CcSEcCtD
Trandolapril—Hepatobiliary disease—Methotrexate—muscle cancer	0.00119	0.00195	CcSEcCtD
Trandolapril—Epistaxis—Methotrexate—muscle cancer	0.00118	0.00194	CcSEcCtD
Trandolapril—Asthenia—Vincristine—muscle cancer	0.00118	0.00194	CcSEcCtD
Trandolapril—Vomiting—Dactinomycin—muscle cancer	0.00117	0.00193	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—muscle cancer	0.00117	0.00192	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—muscle cancer	0.00117	0.00192	CcSEcCtD
Trandolapril—Rash—Dactinomycin—muscle cancer	0.00116	0.00191	CcSEcCtD
Trandolapril—Decreased appetite—Etoposide—muscle cancer	0.00116	0.00191	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—muscle cancer	0.00116	0.0019	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Etoposide—muscle cancer	0.00115	0.00189	CcSEcCtD
Trandolapril—Fatigue—Etoposide—muscle cancer	0.00115	0.00189	CcSEcCtD
Trandolapril—Constipation—Etoposide—muscle cancer	0.00114	0.00188	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—muscle cancer	0.00114	0.00187	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00113	0.00186	CcSEcCtD
Trandolapril—Diarrhoea—Vincristine—muscle cancer	0.00113	0.00185	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—muscle cancer	0.00113	0.00185	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—muscle cancer	0.00113	0.00185	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—muscle cancer	0.00112	0.00184	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—muscle cancer	0.00111	0.00183	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00111	0.00183	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—muscle cancer	0.0011	0.00181	CcSEcCtD
Trandolapril—Feeling abnormal—Etoposide—muscle cancer	0.0011	0.00181	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—muscle cancer	0.0011	0.00181	CcSEcCtD
Trandolapril—Nausea—Dactinomycin—muscle cancer	0.0011	0.0018	CcSEcCtD
Trandolapril—Gastrointestinal pain—Etoposide—muscle cancer	0.00109	0.00179	CcSEcCtD
Trandolapril—Dizziness—Vincristine—muscle cancer	0.00109	0.00179	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—muscle cancer	0.00109	0.00178	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—muscle cancer	0.00109	0.00178	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—muscle cancer	0.00109	0.00178	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—muscle cancer	0.00109	0.00178	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00108	0.00177	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—muscle cancer	0.00107	0.00175	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—muscle cancer	0.00107	0.00175	CcSEcCtD
Trandolapril—Urticaria—Etoposide—muscle cancer	0.00106	0.00174	CcSEcCtD
Trandolapril—Body temperature increased—Etoposide—muscle cancer	0.00106	0.00173	CcSEcCtD
Trandolapril—Abdominal pain—Etoposide—muscle cancer	0.00106	0.00173	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—muscle cancer	0.00106	0.00173	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—muscle cancer	0.00105	0.00173	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—muscle cancer	0.00105	0.00172	CcSEcCtD
Trandolapril—Vomiting—Vincristine—muscle cancer	0.00105	0.00172	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—muscle cancer	0.00105	0.00172	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—muscle cancer	0.00104	0.00171	CcSEcCtD
Trandolapril—Rash—Vincristine—muscle cancer	0.00104	0.00171	CcSEcCtD
Trandolapril—Dermatitis—Vincristine—muscle cancer	0.00104	0.00171	CcSEcCtD
Trandolapril—Headache—Vincristine—muscle cancer	0.00103	0.0017	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00103	0.00169	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—muscle cancer	0.00103	0.00168	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—muscle cancer	0.00102	0.00168	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—muscle cancer	0.00102	0.00167	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—muscle cancer	0.00102	0.00167	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—muscle cancer	0.00101	0.00167	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—muscle cancer	0.000996	0.00163	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—muscle cancer	0.000993	0.00163	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—muscle cancer	0.000987	0.00162	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—muscle cancer	0.000985	0.00162	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—muscle cancer	0.000981	0.00161	CcSEcCtD
Trandolapril—Nausea—Vincristine—muscle cancer	0.00098	0.00161	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—muscle cancer	0.000978	0.00161	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—muscle cancer	0.000976	0.0016	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—muscle cancer	0.000969	0.00159	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—muscle cancer	0.000964	0.00158	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—muscle cancer	0.000961	0.00158	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—muscle cancer	0.000961	0.00158	CcSEcCtD
Trandolapril—Asthenia—Etoposide—muscle cancer	0.000959	0.00157	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—muscle cancer	0.000959	0.00157	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—muscle cancer	0.000957	0.00157	CcSEcCtD
Trandolapril—Back pain—Methotrexate—muscle cancer	0.000949	0.00156	CcSEcCtD
Trandolapril—Pruritus—Etoposide—muscle cancer	0.000946	0.00155	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—muscle cancer	0.00094	0.00154	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—muscle cancer	0.000923	0.00151	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—muscle cancer	0.000915	0.0015	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—muscle cancer	0.000912	0.0015	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—muscle cancer	0.00091	0.00149	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—muscle cancer	0.00091	0.00149	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—muscle cancer	0.000907	0.00149	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—muscle cancer	0.000906	0.00149	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—muscle cancer	0.000906	0.00149	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—muscle cancer	0.000885	0.00145	CcSEcCtD
Trandolapril—Malaise—Methotrexate—muscle cancer	0.000885	0.00145	CcSEcCtD
Trandolapril—Dizziness—Etoposide—muscle cancer	0.000884	0.00145	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—muscle cancer	0.000881	0.00145	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—muscle cancer	0.000881	0.00145	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—muscle cancer	0.00088	0.00144	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—muscle cancer	0.000878	0.00144	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—muscle cancer	0.000872	0.00143	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—muscle cancer	0.000862	0.00142	CcSEcCtD
Trandolapril—Cough—Methotrexate—muscle cancer	0.000856	0.00141	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—muscle cancer	0.000855	0.0014	CcSEcCtD
Trandolapril—Vomiting—Etoposide—muscle cancer	0.00085	0.00139	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—muscle cancer	0.00085	0.00139	CcSEcCtD
Trandolapril—Rash—Etoposide—muscle cancer	0.000843	0.00138	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—muscle cancer	0.000842	0.00138	CcSEcCtD
Trandolapril—Headache—Etoposide—muscle cancer	0.000837	0.00137	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—muscle cancer	0.000837	0.00137	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—muscle cancer	0.000835	0.00137	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—muscle cancer	0.000835	0.00137	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—muscle cancer	0.000835	0.00137	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—muscle cancer	0.000832	0.00137	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00083	0.00136	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—muscle cancer	0.000825	0.00135	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—muscle cancer	0.000822	0.00135	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—muscle cancer	0.000817	0.00134	CcSEcCtD
Trandolapril—Infection—Methotrexate—muscle cancer	0.000795	0.00131	CcSEcCtD
Trandolapril—Nausea—Etoposide—muscle cancer	0.000794	0.0013	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—muscle cancer	0.000788	0.00129	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—muscle cancer	0.000785	0.00129	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—muscle cancer	0.000785	0.00129	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—muscle cancer	0.000784	0.00129	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—muscle cancer	0.000781	0.00128	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—muscle cancer	0.000778	0.00128	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—muscle cancer	0.000774	0.00127	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—muscle cancer	0.000766	0.00126	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—muscle cancer	0.000763	0.00125	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—muscle cancer	0.000763	0.00125	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—muscle cancer	0.000762	0.00125	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—muscle cancer	0.00076	0.00125	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—muscle cancer	0.000751	0.00123	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—muscle cancer	0.000748	0.00123	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—muscle cancer	0.000747	0.00123	CcSEcCtD
Trandolapril—Cough—Doxorubicin—muscle cancer	0.000741	0.00122	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00073	0.0012	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—muscle cancer	0.000724	0.00119	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—muscle cancer	0.000723	0.00119	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—muscle cancer	0.000723	0.00119	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—muscle cancer	0.000723	0.00119	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—muscle cancer	0.000721	0.00118	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—muscle cancer	0.000719	0.00118	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000718	0.00118	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—muscle cancer	0.000715	0.00117	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—muscle cancer	0.000714	0.00117	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—muscle cancer	0.000712	0.00117	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—muscle cancer	0.000707	0.00116	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—muscle cancer	0.000705	0.00116	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—muscle cancer	0.000696	0.00114	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—muscle cancer	0.000693	0.00114	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000691	0.00113	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—muscle cancer	0.00069	0.00113	CcSEcCtD
Trandolapril—Infection—Doxorubicin—muscle cancer	0.000689	0.00113	CcSEcCtD
Trandolapril—Shock—Doxorubicin—muscle cancer	0.000682	0.00112	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—muscle cancer	0.00068	0.00112	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—muscle cancer	0.000679	0.00111	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—muscle cancer	0.000677	0.00111	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—muscle cancer	0.000673	0.00111	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—muscle cancer	0.00067	0.0011	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—muscle cancer	0.000661	0.00108	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—muscle cancer	0.00066	0.00108	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—muscle cancer	0.000655	0.00107	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—muscle cancer	0.000648	0.00106	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—muscle cancer	0.000636	0.00104	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—muscle cancer	0.000633	0.00104	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—muscle cancer	0.000633	0.00104	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000632	0.00104	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—muscle cancer	0.000627	0.00103	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—muscle cancer	0.000623	0.00102	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—muscle cancer	0.000618	0.00101	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—muscle cancer	0.000616	0.00101	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—muscle cancer	0.00061	0.001	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—muscle cancer	0.000603	0.000989	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000599	0.000982	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—muscle cancer	0.000598	0.000981	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—muscle cancer	0.000593	0.000973	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—muscle cancer	0.00059	0.000968	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—muscle cancer	0.000574	0.000943	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—muscle cancer	0.000571	0.000938	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000567	0.000931	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—muscle cancer	0.000566	0.00093	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—muscle cancer	0.000551	0.000904	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—muscle cancer	0.000548	0.0009	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—muscle cancer	0.000548	0.0009	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—muscle cancer	0.000548	0.000899	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—muscle cancer	0.000529	0.000869	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—muscle cancer	0.000511	0.000838	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—muscle cancer	0.000509	0.000836	CcSEcCtD
Trandolapril—Rash—Methotrexate—muscle cancer	0.000505	0.000829	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—muscle cancer	0.000504	0.000828	CcSEcCtD
Trandolapril—Headache—Methotrexate—muscle cancer	0.000502	0.000823	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—muscle cancer	0.000497	0.000816	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—muscle cancer	0.000491	0.000805	CcSEcCtD
Trandolapril—Nausea—Methotrexate—muscle cancer	0.000476	0.000781	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—muscle cancer	0.000474	0.000779	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—muscle cancer	0.000458	0.000752	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—muscle cancer	0.000441	0.000724	CcSEcCtD
Trandolapril—Rash—Doxorubicin—muscle cancer	0.000437	0.000717	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—muscle cancer	0.000437	0.000717	CcSEcCtD
Trandolapril—Headache—Doxorubicin—muscle cancer	0.000434	0.000713	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—muscle cancer	0.000412	0.000676	CcSEcCtD
